Clinical Trial Update: Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing telmisartan to amlodipine in patients with mild-to-moderate hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED